HealthExec August 23, 2024
Evolent Health, a publicly traded company that helps payers and providers develop value-based care plans, is in talks to be acquired by private equity firms, according to reporters from Reuters citing “people familiar with the matter.”
Interested private equity firms include TPG, KKR and Clayton, and Dubilier & Rice (CD&R), according to reporters. Insurer Elevance is among the bidders, but it could “team up” with interested private equity buyers for a minority stake. All have submitted initial bids to acquire Evolent, reporters said. Evolent is currently...
Today's Sponsors
Today's Sponsor